| Features | Number (%) |
|---|---|
| Age (yrs) | |
| ≤ 45 | 60 (48.4%) |
| > 45 | 64 (51.6%) |
| Gender | |
| Male | 64 (51.6%) |
| Female | 60 (48.4%) |
| Residence | |
| Urban | 66 (53.2%) |
| Rural | 58 (48.4%) |
| Family history | |
| - ve | 103 (83.1%) |
| + ve | 21 (16.9%) |
| Smoking | |
| - ve | 88 (71.0%) |
| + ve | 36 (29.0%) |
| PS | |
| 0 | 56 (45.2%) |
| I | 48 (38.7%) |
| II | 20 (16.1%) |
| Pathology | |
| Adenocarcinoma | 105 (84.7%) |
| Mucinous adenocarcinoma | 19 (15.3%) |
| Grade | |
| I-II | 109 (87.9%) |
| III | 15 (12.1%) |
| T. stage | |
| T3 | 84(67.7%) |
| T4 | 32 (25.8%) |
| Missed | 8 (6.5%) |
| Dissected LN | |
| < 12 | 60 (48.4%) |
| ≥ 12 | 64 (51.6%) |
| Adjuvant | |
| No | 30 (24.2%) |
| Yes | 94 (75.8%) |
| Toxicity | |
| No | 69(41.5) |
| Yes | 55(58.5%) |